ALT insider transactions
Altimmune Inc. (ALT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ALT
- SEC Form 4 filed by Director Lawver Teri L4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Sohn Catherine A.4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Jorkasky Diane4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Schafer Klaus4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Pisano Wayne4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Hodges Philip4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Gill John4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Sayare Mitchel4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Gill John4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Weaver Gregory L4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Durso Jerome Benedict4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Roberts M Scot4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Weaver Gregory L4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Scientific Officer Roberts M Scot converted options into 17,050 shares, covered exercise/tax liability with 5,188 shares and was granted 5,567 shares, increasing direct ownership by 18% to 112,824 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Garg Vipin K converted options into 26,775 shares, covered exercise/tax liability with 11,632 shares and was granted 6,926 shares, increasing direct ownership by 5% to 424,519 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Business Officer Jordt Raymond M was granted 4,571 shares, increasing direct ownership by 7% to 70,107 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Business Officer Jordt Raymond M converted options into 15,850 shares and covered exercise/tax liability with 4,229 shares, increasing direct ownership by 22% to 65,536 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Garg Vipin K converted options into 41,200 shares and covered exercise/tax liability with 17,898 shares, increasing direct ownership by 6% to 402,450 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Scientific Officer Roberts M Scot converted options into 15,850 shares and covered exercise/tax liability with 4,748 shares, increasing direct ownership by 13% to 95,395 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Business Officer Jordt Raymond M converted options into 14,600 shares and covered exercise/tax liability with 3,855 shares, increasing direct ownership by 25% to 53,915 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Garg Vipin K converted options into 42,050 shares and covered exercise/tax liability with 17,984 shares, increasing direct ownership by 7% to 379,148 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Scientific Officer Roberts M Scot converted options into 14,600 shares and covered exercise/tax liability with 4,373 shares, increasing direct ownership by 14% to 84,293 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Pisano Wayne bought $20,410 worth of shares (5,000 units at $4.08), increasing direct ownership by 59% to 13,498 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Business Officer Jordt Raymond M converted options into 9,375 shares and covered exercise/tax liability with 2,475 shares, increasing direct ownership by 19% to 43,170 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Sohn Catherine A. bought $2,118 worth of shares (500 units at $4.24), increasing direct ownership by 50% to 1,500 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Jorkasky Diane bought $2,003 worth of shares (527 units at $3.80) (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Gill John bought $51,250 worth of shares (12,500 units at $4.10) (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Durso Jerome Benedict bought $51,569 worth of shares (12,500 units at $4.13) (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by CEO-elect Durso Jerome Benedict4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Financial Officer Weaver Gregory L converted options into 18,750 shares and covered exercise/tax liability with 5,672 shares, increasing direct ownership by 131% to 23,078 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Weaver Gregory L4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Arbet-Engels Christophe4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 3 filed by new insider Arbet-Engels Christophe3 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Sohn Catherine A.4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Durso Jerome Benedict4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Lawver Teri L4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Jorkasky Diane4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Gill John gifted 2,714 shares, closing all direct ownership in the company (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Schafer Klaus4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Sayare Mitchel4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Hodges Philip4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Pisano Wayne4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Richardson Linda M4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 3 filed by new insider Richardson Linda M3 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Business Officer Jordt Raymond M was granted 1,368 shares, increasing direct ownership by 4% to 36,270 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Medical Officer Harris Matthew Scott was granted 2,018 shares, increasing direct ownership by 14% to 16,087 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Scientific Officer Roberts M Scot was granted 846 shares, increasing direct ownership by 1% to 74,066 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Director Sohn Catherine A. bought $5,784 worth of shares (1,000 units at $5.78) (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Financial Officer Weaver Gregory L bought $51,996 worth of shares (10,000 units at $5.20) (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Medical Officer Harris Matthew Scott gifted 67,787 shares (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Lawver Teri L4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 3 filed by new insider Lawver Teri L3 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Durso Jerome Benedict4 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 3 filed by new insider Durso Jerome Benedict3 - Altimmune, Inc. (0001326190) (Issuer)
- SEC Form 4 filed by Director Sohn Catherine A.4 - Altimmune, Inc. (0001326190) (Issuer)
- President and CEO Garg Vipin K converted options into 62,270 shares, covered exercise/tax liability with 27,214 shares and was granted 4,105 shares, increasing direct ownership by 12% to 355,082 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Medical Officer Harris Matthew Scott converted options into 23,216 shares, covered exercise/tax liability with 7,990 shares and was granted 1,905 shares, increasing direct ownership by 26% to 81,856 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)
- Chief Business Officer Jordt Raymond M was granted 2,614 shares, increasing direct ownership by 8% to 34,902 units (SEC Form 4)4 - Altimmune, Inc. (0001326190) (Issuer)